ArticleInternational journal of clinical oncology2026
Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.
Mamoru Hashimoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.